Combinib 250 Mg Tablets

Product Description

Combinib 250mg Tablet should be taken on an empty stomach or an hour before or 2 hours after a meal. The dose and duration vary according to the severity of your condition and your response to treatment. Take it exactly as prescribed to avoid serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, back pain, and breathing difficulty. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. You may be asked for regular monitoring of blood pressure while taking this medicine. Inform your doctor if you notice a severe headache, confusion, problems with your eyesight, nausea, or vomiting. Your doctor may check your liver function before, during, and after treatment with this medicine.

Targeted Cancer Therapy for HER2-Positive Cases

Combinib 250 mg Tablets are specifically formulated for patients with HER2-positive breast cancer and other HER2-expressing cancers. This medicine leverages the targeted action of Lapatinib to inhibit cancer cell growth, providing an effective approach for those battling advanced or metastatic disease. Always consult a physician for tailored dosage and comprehensive treatment planning.


Usage and Administration Guidelines

Administered orally, Combinib 250 mg should be taken exactly as prescribed by a healthcare professional. Adult patients should follow their physician's instructions on dosage and duration. The tablets come in boxes of 30 and must be stored below 30C, safeguarded from light and moisture, to maintain their efficacy throughout the shelf life.